Skip to content

DOCMA

Active
Private limited companyfounded 2018active for 7 yearsHazenpad(LIN) 13, 3210 Lubbeek, BelgiumKBO/BCE: BE 0716.622.835
Summary

DOCMA has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €191,201 and a net result of €33,225. Equity is growing by about 28% per year across the filed financial years. Its solvency ranks better than 18% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
8th largest company by total assets in Lubbeek, Health and social work sector1 site
Size
€1.1mtotal assets 2025
Staff
1 FTE
Equity
€191,201
Profit
€33,225
Turnover not published (abbreviated or micro format)
Financial health
90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Holdings
1
2025 accounts filed 75 days late1 of 2 deeds summarised
Why 90raises riskLast filed accounts filed 75 days late; 1 of the last 3 latelowers riskSector: Human health activities (NACE 86)Size: total assets €1.1mFigures for financial year 2025 (filed 14-10-2026)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 32% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 42+2
equity 17.4% of total assets
Liquidity 53+3
short-term debt 9.0% · cash 2.8%
Profitability 73+2
return on assets 3.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1%lowest value 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%▼ -0.1 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.3%▲ +0.1 percentage points vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.5%▲ +0.2 percentage points vs 07-2026 09-2026: 0.7%▲ +0.2 percentage points vs 08-2026highest value 10-2026: 0.1%▼ -0.6 percentage points vs 09-2026
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.5, compared with 0.21 in 2024, below 1; short-term debt: 9% and cash: 2.8% of total assets), and 82.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 19% on solvency, 28% on liquidity, 16% on profitability and 65% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 75 days late; 1 of the last 3 late
NBB · filings
lowers risk · Size: total assets €1.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 14-10-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 20612 sector peers (2025).
NBB · sector comparison
Position among 20612 sector peers
Solvency
better than 18%
← weakest strongest →
raises risk · 2025 accounts filed 75 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-10-2026, 75 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 7 filings
Deviation from the deadline
2025
75 days late
2024
28 days late
2023
35 days early
2022
66 days late
2021
18 days early
2020
75 days early
2019
54 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (4 of the last 5 filed years within 47 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Equity above €150,000equity €157,976 ▲12%

Financials · financial year 2025, micro format

2025 annual accounts filed late (75 days) Filed on 14 October 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00556657.

Equity
€191,201▲ 21.0%
2024 · €157,976
Total assets
€1.1m▲ 1.3%
2024 · €1.1m
Net result
€33,225▲ 95.8%
2024 · €16,969
Working capital
-€49,168▲ 46.4%
2024 · -€91,800
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

After the dip in 2023 the operating result has climbed two years in a row; 2025 is 11% above 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.06m 2025 Net result€0.03m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result-€0.03m-€0.05m€0.1m▲ 112%€0.05m▼ 59.6%€0.04m▼ 6.9%€0.06m▲ 37.4%€0.06m▲ 11.4%
Net result-€0.04m-€0.03mwithin the sector's middle half€0.09mwithin the sector's middle half▲ 166%€0.03mwithin the sector's middle half▼ 63.1%€0.01mbelow the sector's middle half▼ 63.7%€0.02mbelow the sector's middle half▲ 45.1%€0.03mwithin the sector's middle half▲ 95.8%
Equity-€0.03m-€0.003mbelow the sector's middle half€0.09mwithin the sector's middle half▲ 26×€0.1mwithin the sector's middle half▲ 42.3%€0.1mwithin the sector's middle half▲ 9.0%€0.2mwithin the sector's middle half▲ 12.0%€0.2mwithin the sector's middle half▲ 21.0%
Total assets€1.0m-€1.0mabove the sector's middle half▲ 5.8%€1.3mabove the sector's middle half▲ 27.1%€1.2mabove the sector's middle half▼ 5.8%€1.2mabove the sector's middle half▼ 3.9%€1.1mabove the sector's middle half▼ 6.7%€1.1mabove the sector's middle half▲ 1.3%
Debt€1.0m-€1.0m▲ 2.3%€1.2m▲ 18.5%€1.1m▼ 9.4%€1.0m▼ 5.5%€0.9m▼ 9.3%€0.9m▼ 2.0%
Working capital-€0.2m--€0.2mbelow the sector's middle half▲ 23.7%-€0.1mbelow the sector's middle half▲ 34.9%-€0.1mbelow the sector's middle half▼ 7.0%-€0.07mbelow the sector's middle half▲ 38.0%-€0.09mbelow the sector's middle half▼ 28.9%-€0.05mbelow the sector's middle half▲ 46.4%
Solvency-3.1%-0.3%below the sector's middle half▲ 3.4pp7.1%below the sector's middle half▲ 6.7pp10.7%below the sector's middle half▲ 3.6pp12.1%below the sector's middle half▲ 1.4pp14.6%below the sector's middle half▲ 2.4pp17.4%below the sector's middle half▲ 2.8pp
Current ratio0.30-0.42below the sector's middle half▲ 0.120.48below the sector's middle half▲ 0.060.27below the sector's middle half▼ 0.220.45below the sector's middle half▲ 0.190.21below the sector's middle half▼ 0.250.50below the sector's middle half▲ 0.29
Return on assets (ROA)-4.4%-3.3%below the sector's middle half▲ 7.6pp6.8%below the sector's middle half▲ 3.6pp2.7%below the sector's middle half▼ 4.1pp1.0%below the sector's middle half▼ 1.7pp1.6%below the sector's middle half▲ 0.6pp3.0%below the sector's middle half▲ 1.5pp
Staff (FTE)0.1below the sector's middle half1▲ 900%1=1=1=1=
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets €1.0m ▼ 1.1%
Current assets €49,308 ▲ 107%
Equity and liabilities €1.1m
Equity €191,201 ▲ 21.0%
Debt €906,908 ▼ 2.0%
Debt's share of the balance-sheet total falls from 85.4% to 82.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€144,378▲
2024 · €121,270
Cash flow
€112,768▲
2024 · €80,036
Debt to equity
4.74▼
2024 · 5.86
ROE
17.4%▲
2024 · 10.7%
Interest coverage
7.92▲
2024 · 6.09
Debt ≤ 1 year
€98,476▼
2024 · €115,624
Debt > 1 year
€808,432▼
2024 · €810,184
Income taxes
€13,729▼
2024 · €21,641
Staff costs
€11,951▲
2024 · €11,290
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,274 companies that looked in July 2024 the way this one looks now, 2.5% went bankrupt within 24 months and 94.6% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
2.5% went bankrupt
2.5% stopped otherwise
94.6% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,274 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.1m€1.1m▲
Fixed assets21/28€1.1m€1.0m▼
Tangible fixed assets22/27€1.1m€1.0m▼
Land and buildings22€1.1m€1.0m▼
Plant, machinery and equipment23-€0.003m
Furniture and vehicles24€0.005m€0.03m▲
Other tangible fixed assets26€0.002m€0.002m=
Financial fixed assets28€0.003m€0.003m=
Current assets29/58€0.02m€0.05m▲
Amounts receivable within one year40/41€0.02m€0.01m▼
Trade receivables40-€482
Other amounts receivable41€0.02m€0.01m▼
Current investments50/53-€0.004m
Cash at bank and in hand54/58€0.007m€0.03m▲
Deferred charges and accrued income490/1€133€0.004m▲
Equity and liabilities
Total equity and liabilities10/49€1.1m€1.1m▲
Equity10/15€0.2m€0.2m▲
Contributions10/11€0.02m€0.02m=
Profit (loss) carried forward14€0.1m€0.2m▲
Amounts payable17/49€0.9m€0.9m▼
Amounts payable after more than one year17€0.8m€0.8m▼
Financial debts170/4€0.8m€0.8m▼
Amounts payable within one year42/48€0.1m€0.1m▼
Current portion of amounts payable after more than one year42€0.08m€0.08m▲
Trade debts44€0.008m€0.02m▲
Suppliers440/4€0.008m€0.02m▲
Taxes, remuneration and social security45€0.003m€0.001m▼
Remuneration and social security454/9€0.003m€0.001m▼
Other amounts payable47/48€0.02m-
Income statement Code20242025
Remuneration, social security and pensions62€0.01m€0.01m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.06m€0.08m▲
Other operating charges640/8€0.003m€0.005m▲
Gross operating margin9900€0.1m€0.2m▲
Operating profit (loss)9901€0.06m€0.06m▲
Financial income75/76B€323€358▲
Recurring financial income75€323€358▲
Financial charges65/66B€0.02m€0.02m▼
Recurring financial charges65€0.02m€0.02m▼
Profit (loss) for the period before taxes9903€0.04m€0.05m▲
Income taxes67/77€0.02m€0.01m▼
Profit (loss) for the period9904€0.02m€0.03m▲
Profit (loss) for the period to be appropriated9905€0.02m€0.03m▲
Appropriation of the result
Profit (loss) to be appropriated9906€0.1m€0.2m▲
Profit (loss) brought forward from the previous period14P€0.1m€0.1m▲

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2019202020212022202320242025Change
Remuneration, social security and pensions62--€14,357€13,689€14,661€11,290€11,951▲ 5.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€138,209€50,170€61,320€72,383€65,940€63,067€79,543▲ 26.1%
Other operating charges640/8--€2,407€3,120€3,393€3,280€4,612▲ 40.6%
Gross operating margin9900€110,317€114,707€190,769€134,680€126,344€135,839€160,940▲ 18.5%
Operating profit (loss)9901-€32,387€53,276€112,684€45,487€42,351€58,202€64,835▲ 11.4%
Financial income75/76B--€408€16,205€126€323€358▲ 11.1%
Recurring financial income75--€408€126€126€323€358▲ 11.1%
Non-recurring financial income76B---€16,079----
Financial charges65/66B--€17,471€19,730€19,068€19,915€18,240▼ 8.4%
Recurring financial charges65€9,145€15,650€17,471€19,730€19,068€19,915€18,240▼ 8.4%
Profit (loss) for the period before taxes9903-€41,532€37,626€95,621€41,963€23,409€38,609€46,954▲ 21.6%
Income taxes67/77€260€4,753€8,237€9,717€11,713€21,641€13,729▼ 36.6%
Profit (loss) for the period9904-€41,792€32,873€87,385€32,245€11,696€16,969€33,225▲ 95.8%
Profit (loss) for the period to be appropriated9905-€41,792€32,873€87,385€32,245€11,696€16,969€33,225▲ 95.8%
Line2019202020212022202320242025Change
Assets
Total assets20/58€1.0m€1.0m€1.3m€1.2m€1.2m€1.1m€1.1m▲ 1.3%
Fixed assets21/28€0.9m€0.9m€1.2m€1.2m€1.1m€1.1m€1.0m▼ 1.1%
Tangible fixed assets22/27€0.9m€0.9m€1.2m€1.2m€1.1m€1.1m€1.0m▼ 1.1%
Land and buildings22--€1.2m€1.2m€1.1m€1.1m€1.0m▼ 3.9%
Plant, machinery and equipment23------€0.003m-
Furniture and vehicles24--€0.009m€0.01m€0.008m€0.005m€0.03m▲ 505%
Other tangible fixed assets26---€0.002m€0.002m€0.002m€0.002m=
Financial fixed assets28€0.003m€0.003m€0.003m€0.003m€0.003m€0.003m€0.003m=
Current assets29/58€0.09m€0.1m€0.1m€0.04m€0.06m€0.02m€0.05m▲ 107%
Amounts receivable within one year40/41€0.03m€0.04m€0.05m€0.03m€0.02m€0.02m€0.01m▼ 32.8%
Trade receivables40--€0.01m€0.02m€0.009m-€482-
Other amounts receivable41--€0.03m€0.01m€0.01m€0.02m€0.01m▼ 35.7%
Current investments50/53------€0.004m-
Cash at bank and in hand54/58€0.07m€0.08m€0.05m€0.01m€0.03m€0.007m€0.03m▲ 341%
Deferred charges and accrued income490/1--€0.003m€0.001m-€133€0.004m▲ 27×
Equity and liabilities
Total equity and liabilities10/49€1.0m€1.0m€1.3m€1.2m€1.2m€1.1m€1.1m▲ 1.3%
Equity10/15-€0.03m€0.003m€0.09m€0.1m€0.1m€0.2m€0.2m▲ 21.0%
Contributions10/11€0.01m-€0.01m€0.02m€0.02m€0.02m€0.02m=
Profit (loss) carried forward14-€0.04m-€0.009m€0.08m€0.1m€0.1m€0.1m€0.2m▲ 23.8%
Amounts payable17/49€1.0m€1.0m€1.2m€1.1m€1.0m€0.9m€0.9m▼ 2.0%
Amounts payable after more than one year17€0.7m€0.7m€1.0m€0.9m€0.9m€0.8m€0.8m▼ 0.2%
Financial debts170/4--€1.0m€0.9m€0.9m€0.8m€0.8m▼ 0.2%
Amounts payable within one year42/48€0.3m€0.3m€0.2m€0.2m€0.1m€0.1m€0.1m▼ 14.8%
Current portion of amounts payable after more than one year42--€0.07m€0.07m€0.07m€0.08m€0.08m▲ 2.6%
Trade debts44€0.003m€0.003m€0.006m€0.01m€0.009m€0.008m€0.02m▲ 90.9%
Suppliers440/4--€0.006m€0.01m€0.009m€0.008m€0.02m▲ 90.9%
Taxes, remuneration and social security45--€0.005m€0.003m€0.003m€0.003m€0.001m▼ 66.1%
Taxes450/3--€0.005m€0.002m€0.002m---
Remuneration and social security454/9---€0.001m€0.001m€0.003m€0.001m▼ 66.1%
Other amounts payable47/48--€0.1m€0.07m€0.05m€0.02m--
Line2019202020212022202320242025Change
Profit (loss) for the period9904-€41,792€32,873€87,385€32,245€11,696€16,969€33,225▲ 95.8%
+ Depreciation and write-downs630€138,209€50,170€61,320€72,383€65,940€63,067€79,543▲ 26.1%
Operating cash flow (approximation)€96,417€83,043€148,705€104,629€77,636€80,036€112,768▲ 40.9%
Investment in fixed assets (approximation)--€81,037-€353,674-€56,525-€1,350-€19,885-€68,384▼ 244%
Change in cash-€17,019-€31,014-€38,971€21,945-€27,692€23,440-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (7)
Financial year Type Filed Reference
31-12-2025 micro format 14-10-2026 2026-00556657
31-12-2024 micro format 28-08-2025 2025-00416866
31-12-2023 micro format 26-06-2024 2024-00161932
31-12-2022 micro format 05-10-2023 2023-00472422
31-12-2021 micro format 13-07-2022 2022-20178665
31-12-2020 micro format 17-05-2021 2021-14100331
31-12-2019 abbreviated format 23-09-2020 2020-54700392

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, last change in 2023
MICHIELS Maarten
Director (not named in the articles) · since 17-05-2023
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
1 of this company's 2 Belgian Official Gazette deeds has not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

1 person since 2023, 1 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
MICHIELS Maarten
  • Manager, until 17-05-2023
  • Director (not named in the articles), from 17-05-2023 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years
  1. 17-05-2023 Converted to unavailable equity

Group and network

Holdings and subsidiaries

1 holding

Holdings 1

According to the 2023 annual accounts of DOCMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 19 December 2018, DOCMA was incorporated.1 Total assets went from €954,119 in 2019 to €1.1m in 2025 and headcount from 0.1 full-time equivalents in 2020 to 1 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019, 2020 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
14-10
NBB filing Annual accounts filed
financial year 2025 · micro format · 75 days late
2025
28-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 28 days late
2024
31-12
Financial Equity above €150,000equity €157,976 ▲12%
5 profitable years in a row build equity to €157,976.
26-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
05-10
NBB filing Annual accounts filed
financial year 2022 · micro format · 66 days late
17-05
Gazette deed Resignation: MICHIELS Maarten (manager)
Appointment: MICHIELS Maarten (director) · Amendment of the articles · Capital conversion9 facts ▸
  • Amendment of the articles (2 times)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “middelen beschikbaar voor uitkering, vormen en meerderheden van statutenwijziging” (deed in Dutch)
  • Other provision, “statutair onbeschikbaar eigen vermogen” (deed in Dutch)
  • Director resignation, MICHIELS Maarten (manager)
  • Director appointment, MICHIELS Maarten (director (not named in the articles))
  • Other provision, “kwijting ontslagnemende zaakvoerder, beslissen over kwijting voor uitoefening mandaat” (deed in Dutch)
  • Registered office clause, “3210 Lubbeek (Linden)” (deed in Dutch)
  • Power of attorney
2022
31-12
Financial Equity above €100,000equity €129,311 ▲42.3%
3 profitable years in a row build equity to €129,311.
13-07
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Highest result from 2019 to 2025net €87,385 ▲166%
Operating result €112,684, net result €87,385, both a record.
17-05
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial Back to profitnet €32,873
Net result €32,873 after one loss-making year.
23-09
NBB filing Annual accounts filed
financial year 2019 · abbreviated format · 54 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded19-12-2018
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
Contact
Phone 000000000Lubbeek
E-invoicing
Reachable via Peppol
Peppol ID 0208:0716622835
Also 9925:BE0716622835
Registered 16-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 27 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Lubbeek · 1 establishment unit since 2018
registered office establishment The establishment unit on the map
Ground area
1,951 m²
Building footprint
285 m²
Building volume
2,407 m³
Parcel 24063A0014/00T002, Flanders · tallest building 25.5 m. Linked by address, not a title deed.
1 establishment unit
DOCMA
Hazenpad(LIN) 13, 3210 LubbeekGeneral medical practice
since 2018unit no. 2.284.604.673
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
24063A0014/00T002 Flanders 1,951 m² 1 · 285 m² 25.5 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“De vennootschap heeft tot voorwerp,de uitoefening door de artsen-vennoten van hun volledige zelfstandige medische activiteit als artsen,meer…” (deed in Dutch)
4 activities (deed in Dutch)
  1. De vennootschap heeft tot voorwerp,de uitoefening door de artsen-vennoten van hun volledige zelfstandige medische activiteit als artsen,meer bepaald algemene geneeskunde,door de artsen-vennoten in naam en voor rekening van de vennootschap,met inachtname van de regels van de geneeskundige plichtenleer.
  2. De vennootschap kan bovendien alle werkzaamheden en rechtshandelingen verrichten die van aard zijn rechtstreeks de verwezenlijking van haar voorwerp te bevorderen.
  3. De vennootschap mag deelnemen aan alle ondernemingen die een gelijkaardig voorwerp nastreven.
  4. De vennootschap mag,als bijkomstig voorwerp,beleggen in roerende en onroerende goederen,op voorwaarde dat deze handelingen niet van aard zijn het burgerlijk karakter van de vennootschap te wijzigen.

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
DOCMA
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, bestuursorgaan kan bij enkel besluit administratieve zetels,agentschappen,werkhuizen,stapelplaatsen en bijkantoren vestigen…” (deed in Dutch)

deed of 17-05-2023

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
“Artikel 13. Bevoegdheden van het bestuursorgaan BESTUURSBEVOEGDHEID §1. Als er slechts één bestuurder is, is het geheel van de bevoegdheden…”
Board ruleHow the board is made up, meets and takes decisions.
“Bestuursorgaan, duur van medische activiteiten binnen vennootschap” (deed in Dutch)
“Algemene kosten,los van representatie-,reis- en verplaatsingskosten, vaste of evenredige vergoeding” (deed in Dutch)

deed of 17-05-2023

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
One provision in the deed
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Nominale waarde verhoogd met aandeel in reserves zoals blijkt uit laatste neergelegde jaarrekening, elke overdracht onder…” (deed in Dutch)
Share issue ruleHow and by whom new shares can be issued.
One provision in the deed

deed of 17-05-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
First Friday of May at 20:00

deed of 17-05-2023

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Beslissing algemene vergadering beslissende in vormen vereist voor statutenwijziging” (deed in Dutch)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Beroep op artsen voor zaken betreffende persoonlijke levenssfeer patiënten en/of beroepsgeheim aandeelhouder(s), bestuurder(s) in functie…” (deed in Dutch)

deed of 17-05-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Inbrengen, 100” (deed in Dutch)
Other provision: “Stortingsplicht, bepaalt vrij naargelang behoeften en op door hem bepaalde tijdstippen latere stortingen op in speciën onderschreven niet…” (deed in Dutch)
Other provision: “Aansprakelijkheid,schorsingen,professionele autonomie, alle artsen-aandeelhouders volledige diagnostische en therapeutische vrijheid” (deed in Dutch)
Other provision: “3 jaar, één of meerdere commissarissen” (deed in Dutch)
Other provision: “Toegang tot algemene vergadering, deelname zonder stemming indien enkel stemrechten geschorst” (deed in Dutch)
Other provision: “Bestuurder, bij gebrek aandeelhouder met meeste aandelen, bij pariteit oudste, zittingen processen-verbaal algemene vergadering” (deed in Dutch)
Other provision: “Schriftelijke volmacht aan ieder ander persoon, aandeelhouder of niet, door alle middelen van overdracht, beraadslagingen algemene…” (deed in Dutch)
Other provision: “Bestuursorgaan tijdens zitting, gewone, bijzondere of buitengewone algemene vergadering” (deed in Dutch)
Other provision: “Bestemming winst reserves, algemene vergadering” (deed in Dutch)
Liquidation distribution: “Aanzuivering schulden, lasten en kosten of consignatie nodige sommen, netto actief en goederen in natura onder alle aandeelhouders naar…” (deed in Dutch)
Other provision: “Alle mededelingen, aanmaningen, dagvaardingen en betekeningen geldig, woonstkeuze” (deed in Dutch)
Other provision: “Rechtbank in wiens rechtsgebied zetel is gevestigd, gerechtelijke bevoegdheid” (deed in Dutch)
Other provision: “Wetboek van vennootschappen en verenigingen, gemeen recht” (deed in Dutch)
1 more provision in the deed, see the deed of 17-05-2023

deed of 17-05-2023